Literature DB >> 25414419

Modeling mucosal cell-associated HIV type 1 transmission in vitro.

Deborah J Anderson1.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) can efficiently spread by direct cell-to-cell contact, a mechanism termed cell-associated HIV transmission. By some estimates, cell-associated HIV transmission is 10-1000-fold more effective than cell-free HIV infection. Mucosal cell-associated HIV transmission may occur when HIV-bearing cells in mucosal secretions from an HIV-infected donor transfer virus directly to recipient target cells in or below the mucosal epithelium, or through HIV transcytosis across the mucosal epithelium of a noninfected host. This mechanism may play an important role in the sexual and vertical transmission of HIV-1, yet most in vitro tests of vaccine and microbicide efficacy assess cell-free virus transmission. This article reviews in vitro assays that have been used to model mucosal cell-associated transmission, including microscopy, immune cell cocultures, use of HIV-infected cells in epithelial cell transcytosis assays, and cell-associated infection of mucosal tissue explants. Assays that authentically simulate mucosal cell-associated HIV transmission could provide valuable insight into mechanisms and molecules that can potentially be targeted for HIV prevention, as well as critical models for testing novel HIV prevention strategies for efficacy against cell-associated HIV transmission.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV-1; cell-associated transmission; genital tract; in vitro; microbicides; mucosa; prevention; vaccines; vagina

Mesh:

Year:  2014        PMID: 25414419      PMCID: PMC4303080          DOI: 10.1093/infdis/jiu537

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  71 in total

Review 1.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

2.  Early events in HIV transmission through a human reconstructed vaginal mucosa.

Authors:  Marielle Bouschbacher; Morgane Bomsel; Estelle Verronèse; Sandrine Gofflo; Yonatan Ganor; Colette Dezutter-Dambuyant; Jenny Valladeau
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

3.  Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates.

Authors:  Y Ganor; Z Zhou; D Tudor; A Schmitt; M-C Vacher-Lavenu; L Gibault; N Thiounn; J Tomasini; J-P Wolf; M Bomsel
Journal:  Mucosal Immunol       Date:  2010-06-23       Impact factor: 7.313

4.  Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.

Authors:  Jeffrey Pudney; Alison J Quayle; Deborah J Anderson
Journal:  Biol Reprod       Date:  2005-08-10       Impact factor: 4.285

5.  HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer.

Authors:  Annette Alfsen; Huifeng Yu; Aude Magérus-Chatinet; Alain Schmitt; Morgane Bomsel
Journal:  Mol Biol Cell       Date:  2005-06-22       Impact factor: 4.138

6.  PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Cristina Rodriguez-Padilla
Journal:  J Nanobiotechnology       Date:  2010-07-13       Impact factor: 10.435

7.  High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy.

Authors:  Christopher J A Duncan; Rebecca A Russell; Quentin J Sattentau
Journal:  AIDS       Date:  2013-09-10       Impact factor: 4.177

8.  Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.

Authors:  Irene A Abela; Livia Berlinger; Merle Schanz; Lucy Reynell; Huldrych F Günthard; Peter Rusert; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

Review 9.  Avoiding the void: cell-to-cell spread of human viruses.

Authors:  Quentin Sattentau
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

10.  Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.

Authors:  Marine Malbec; Françoise Porrot; Rejane Rua; Joshua Horwitz; Florian Klein; Ari Halper-Stromberg; Johannes F Scheid; Caroline Eden; Hugo Mouquet; Michel C Nussenzweig; Olivier Schwartz
Journal:  J Exp Med       Date:  2013-11-25       Impact factor: 14.307

View more
  9 in total

1.  New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif.

Authors:  S Abigail Smith; Cynthia A Derdeyn
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

2.  The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.

Authors:  Suiyi Tan; Jin-Qing Li; Hongyan Cheng; Zhaofeng Li; Yan Lan; Ting-Ting Zhang; Zi-Chao Yang; Wenjuan Li; Tao Qi; Yu-Rong Qiu; Zhipeng Chen; Lin Li; Shu-Wen Liu
Journal:  J Biol Chem       Date:  2019-07-25       Impact factor: 5.157

3.  Cell-associated HIV mucosal transmission: the neglected pathway.

Authors:  Deborah J Anderson; Roger Le Grand
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

4.  The BLT Humanized Mouse Model as a Tool for Studying Human Gamma Delta T Cell-HIV Interactions In Vivo.

Authors:  Shivkumar Biradar; Yash Agarwal; Michael T Lotze; Moses T Bility; Robbie B Mailliard
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

Review 5.  Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir.

Authors:  Kyle D Pedro; Andrew J Henderson; Luis M Agosto
Journal:  Virus Res       Date:  2019-03-21       Impact factor: 3.303

Review 6.  Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.

Authors:  Deborah J Anderson; Joseph A Politch; Larry Zeitlin; Andy Hiatt; Kadryn Kadasia; Kenneth H Mayer; Ruth M Ruprecht; Francois Villinger; Kevin J Whaley
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.632

Review 7.  Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection.

Authors:  Matthew S Parsons; Roger Le Grand; Stephen J Kent
Journal:  Viruses       Date:  2018-06-18       Impact factor: 5.048

8.  The importance of semen leukocytes in HIV-1 transmission and the development of prevention strategies.

Authors:  Mariangela Cavarelli; Roger Le Grand
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

9.  Chlamydia trachomatis Infection of Endocervical Epithelial Cells Enhances Early HIV Transmission Events.

Authors:  Lyndsey R Buckner; Angela M Amedee; Hannah L Albritton; Pamela A Kozlowski; Nedra Lacour; Chris L McGowin; Danny J Schust; Alison J Quayle
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.